Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study of methotrexate for erosive hand osteoarthritis refractory to standard treatments is described, with the trial currently not recruiting.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Erosive Hand Osteoarthritis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING